<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">ol{margin:0;padding:0}table td,table th{padding:0}.c5{-webkit-text-decoration-skip:none;color:#000000;font-weight:700;text-decoration:underline;vertical-align:baseline;text-decoration-skip-ink:none;font-size:11pt;font-family:"Arial";font-style:normal}.c0{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c2{color:#000000;font-weight:700;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c1{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c4{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:center}.c7{background-color:#ffffff;max-width:602pt;padding:7.1pt 2.9pt 0pt 7.1pt}.c3{height:11pt}.c6{font-weight:700}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c7"><p class="c4"><span class="c5">INTRO</span></p><p class="c3 c4"><span class="c5"></span></p><p class="c1"><span class="c0">Used previously developed transmission model and incorporated three scenarios of vaccination efficacy: reduction of susceptibility, reduction of probability of becoming symptomatic, and finally the weakest being that which only protects against symptoms becoming severe.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">Initially for each vaccine-type predict possible scenarios using vaccine efficacy which is dependant on parameters population additionally they consider prioritization vaccinations specific groups depending on health conditions and age group</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">The novelty of this research is that they use an optimization based on quality adjusted life year saved (QALY metrics) which allows for an accounting in terms of the economic impact of each dose, &nbsp;this approach is not completely in line with the common health economic approaches used until now.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">They utilised the compartmental (SEIR) age structure model in order to simulate spread of covid 2 in the UK &nbsp;with considerations of death hospitalization Hospital occupancy and serological testing</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1 c3"><span class="c0"></span></p><p class="c4"><span class="c5">METHODS</span></p><p class="c4 c3"><span class="c5"></span></p><p class="c1"><span class="c6">Transmission Model</span></p><p class="c1"><span class="c0">This model is a stratified and the force of &nbsp;infection was pound based on each dependant social contact matrices for UK,</span></p><p class="c1"><span>&nbsp;considerations of household isolation we&#39;re done through allowing first infections and household cause secondary infections, all model parameters were inferred based on regional data.</span><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 390.50px; height: 273.35px;"><img alt="" src="images/image2.png" style="width: 390.50px; height: 273.35px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c1"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 393.50px; height: 228.91px;"><img alt="" src="images/image1.png" style="width: 393.50px; height: 228.91px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c2">Comorbidity</span></p><p class="c1"><span>C</span><span class="c0">reated a heuristic in order to better aggregate the various &nbsp;risks associated to comorbidities. This implies &nbsp;that people in a specific age group with comorbidities like twice as likely to die than those without. Comorbidities that have an increased risk of infection are most common in those over 75 years of age.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 624.00px; height: 268.00px;"><img alt="" src="images/image3.png" style="width: 624.00px; height: 268.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c1 c3"><span class="c2"></span></p><p class="c1"><span class="c2">Social measures</span></p><p class="c1"><span class="c0">Social distancing has been &nbsp;represented in the model through the reduction in the corresponding contact &nbsp;matrices, with quarantine having a state of its very own, and a drastically reduced contact matrix. On the flip side this will correspond to an increase in the matrices associated to places of social isolation. </span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">&nbsp;due to the expectation of continued use of social distancing they simulate a first wave and then a continuation of lock-down measures &nbsp;until completion of vaccinations.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">the success of any vacation program is highly dependant on non-pharmaceutical interventions at the time of vaccination here comparison is done between a &nbsp;complete lifting of NPI with the scenario of a limited amount of non-pharmaceutical interventions prior to initiation of vaccinations. </span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 624.00px; height: 282.67px;"><img alt="" src="images/image4.png" style="width: 624.00px; height: 282.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c2">Vaccination</span></p><p class="c1"><span class="c0">Three different levels of protection were considered</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">Type 1 reduction in susceptibility</span></p><p class="c1"><span class="c0">Type 2 reduction in becoming symptomatic</span></p><p class="c1"><span>Type 3 &nbsp;reduction in experiencing severe symptoms </span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c2">Simulation Setup</span></p><p class="c1"><span class="c0">Model was run to &nbsp;create baseline without vaccination for all of 2020, as in this timeperiod R is a little bit below one.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">Then for 2021, &nbsp;to represent the initiation of vaccination a portion of the population is transferred to vaccinate date where the action of infection &nbsp;is dependant on the vaccine type.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">&nbsp;the optimal approaches are listed below. </span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c6">Priority Order: </span><span class="c0">criterion of selection was deaths, as well QALY lost, both post 2021.</span></p><p class="c1"><span class="c0">Divided pop into 20 age groups, and set aside a group of comorbidities independent of age, and then analysed optimal ordering of vaccination of these groups.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c6">Prioritization of HCW: </span><span class="c0">Given an increased exposure of about 11x the normal pop, and a ~3x risk of infection, they translated this risk into an adjustment of susceptibility in the model. &nbsp;</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c6">Sensitivity to Level of Protection: </span><span>assuming a max of</span><span class="c0">&nbsp;70% vaccination for each of the aforementioned groups, the sensitivity analysis based on the two criteria above was done based vaccines efficacies of 50% , 70% and 90%, for each of the levels of protection detailed above.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c6">Sensitivity to speed of vaccine deployment:</span><span class="c0">&nbsp;assumption is time to vaccinate the population and them obtaining immunity, is small in duration, which has little impact if the reproduction number R is below one while the vaccine program is being undertaken. A slower deployment with weaker NPIs with R significantly more than 1 (1.8) is also considered, with a 2month delay in Type 2 Vaccination (70% Efficacy). &nbsp;Gradual delivery dynamics are simulated by computing the results based on 24hr intervals, with a fixed portion of the susceptibles or asymptomatic class being successfully immunised at each timestep.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c6">Sensitivity to age-dependent efficacy. </span><span>It is suggestive that the severity of SARS-CoV-2 &nbsp;is </span><span class="c0">dependent on age, so a vaccine that is also efficacious based on age could have varying impact, the focus of this part of the work is if an age-dependent decline in efficacy would effect the prioritization. Tested for reduced vaccine effectiveness in the elderly using varying efficacy profiles where base efficacy would be uniform for the age groups under 45 with linearly declining efficacy to a minimal value shared by those above the age of 85.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1"><span class="c0">100 simulations were done for each vaccine type, efficacy and priority. Each simulation used a distinct parameter set that was pulled from posterior parameter distributions, that were compiled based on the inference methods used to tune the models for the available covid19 health outcome data streams for the UK.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c4"><span class="c5">RESULTS</span></p><p class="c4 c3"><span class="c5"></span></p><p class="c1"><span class="c2">Selection of Priority Order</span></p><p class="c1"><span class="c0">Minimization of QALY Loss or Deaths, gave similar results.</span></p><p class="c1"><span class="c0">Age based approach found that oldest first as the highest efficacy.</span></p><p class="c1"><span class="c0">A strong correlation is found between age and prevalence of comorbidities, and as such age based approach is already effective in targeting vulnerable groups. (not sure about last line of paragraph referring to cost-benefit of focusing on all age groups with comorbidities, when limited supply)</span></p><p class="c1 c3"><span class="c5"></span></p><p class="c1"><span class="c2">HCW</span></p><p class="c1"><span class="c0">Using a Type1 vaccine, HCW come in second in priority to the elderly (80+). Important to note this only in terms of personal risk and not in terms of their capacity to be amplified spreaders, this prioritization is not challenging given the small proportion of HCW to the total population. For the Type2 and 3, they stop being a priority for vaccination.</span></p><p class="c1 c3"><span class="c0"></span></p><p class="c1 c3"><span class="c2"></span></p></body></html>